If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
217.50    0.00 (0.00%)
Bid:
215.00
Ask:
220.00
Spread: 5.00 (2.326%)
Market Cap: £148.38m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Quarterly Syndicate Mid-point Forecasts

26 Nov 2021 07:00

RNS Number : 6478T
Helios Underwriting Plc
26 November 2021
 

26 November 2021

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Quarterly Syndicate Mid-point Forecasts

 

Helios, the unique investment vehicle which acquires and consolidates private underwriting capacity at Lloyd's, announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2019 and 2020 years of account based on 3rd quarter 2021 estimates.

 

Nigel Hanbury, Chief Executive, commented:

 

"As the only listed consolidator of private capital at Lloyd's, Helios continues to build a diversified and unique portfolio of insurance risk with top performing syndicates, having completed 21 acquisitions of Limited Liability Vehicles in the last three months, acquiring £22.7m of capacity on the 2021 underwriting year. Our strategy is bringing results, increasing our retained capacity to £81m for 2021 in a year where pricing, terms and conditions of the business underwriter have continued to improve.

We look forward to creating further shareholder value."

 

 

Year of Account

 

2019

2020

2021

 

£m

£m

£m

Capacity - Position as at 19th August 2021

 

 

 

Retained

31.3

30.9

58.6

Reinsured

39.0

49.1

51.6

 

70.3

80.0

110.2

 

 

 

 

Capacity Acquired since 19th August 2021

 

 

 

Retained

24.0

23.4

22.7

Reinsured

-

-

-

 

24.0

23.4

22.7

 

 

 

 

Total Capacity as at 25th November 2021

Retained

 

55.3

 

54.3

 

81.3

Reinsured

39.0

49.1

51.6

 

94.3

103.4

132.9

 

 

 

 

 

 

 

 

 

 

 

 

Mid-point forecast at 19th August 2021

0.01%

0.98%

 

Current mid-point forecast

0.65%

0.77%

 

 

 

 

 

Lloyd's Market Average

-3.50%

0.59%

 

Helios outperformance

4.15%

0.18%

 

 

Commentary

 

The mid-point forecasts have been calculated using the enlarged capacity including the capacity recently acquired. The midpoint estimate on a like for like basis using the capacity portfolio as at 19th August 2021 are as follows:

 

 

 

 

2019 YOA

2020 YOA

Mid-point forecast at 19th August 2021

0.01%

0.98%

Current mid-point forecast - "like for like portfolio"

1.40%

1.03%

 

The improvement in the results of the underlying portfolio before the effect of the capacity recently acquired continues to be in line with expectations. The 2019 current estimate shows a welcome increase over the estimate as at 19 August 2021. For 2020 underwriting year, there is a small improvement in the mid-point estimate in the underlying portfolio.

 

The outperformance of 4.15% of the portfolio against the average for the Lloyd's market for 2019 continues the trend of outperformance achieved over the last 6 years that averages over 4.7% during the period.

 

Notes

1) The table above shows the capacity as at 25th November 2021 splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers. 

2) The mid-point forecasts for 2019 and 2020 years of account as of 3rd quarter 2021 have been aggregated at syndicate level from estimates supplied by Managing Agents.

3) The impact on Helios will be as follows:

a. The change in the mid-point estimates on the retained capacity over the year will be recognised in the Helios income statement in the year to 31st December 2021.

b. The overall change in the result will be recognised by Helios in cash at the close of the year of account.

 

For further information, please contact:

Helios Underwriting plc

Nigel Hanbury - Chief Executive +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Shore Capital

Robert Finlay +44 (0)20 7601 6100

David Coaten

 

Willis Re Securities (Financial Adviser)

Alastair Rodger +44 (0)20 3124 6033

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £133m of capacity for the 2021 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGWWGUPGGQA
Date   Source Headline
8th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20233:27 pmRNSTransaction in Own Shares
4th Sep 20233:36 pmRNSTransaction in Own Shares
1st Sep 202311:06 amRNSTransaction in Own Shares
1st Sep 20237:00 amRNSTotal Voting Rights
31st Aug 202311:05 amRNSTransaction in Own Shares
30th Aug 20234:05 pmRNSTransaction in Own Shares
30th Aug 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
29th Aug 202312:30 pmRNSTransaction in Own Shares
25th Aug 20232:12 pmRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in own shares
23rd Aug 202311:44 amRNSShare Repurchase Programme
21st Aug 20234:23 pmRNSNotification of Major Holdings
21st Aug 202311:40 amRNSDirector's Shareholding
18th Aug 20238:22 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20234:30 pmRNSShare Repurchase Programme
2nd Aug 20237:00 amRNSTotal Voting Rights
25th Jul 20237:00 amRNSAcquisition
14th Jul 20237:00 amRNSDirector Dealing
14th Jul 20237:00 amRNSAcquisition of Limited Liability Vehicle
13th Jul 20237:00 amRNSIssue of Equity
4th Jul 20237:00 amRNSResults of Scrip Dividend Election
29th Jun 20233:46 pmRNSDirectorship Change
29th Jun 202311:27 amRNSResults of Annual General Meeting
29th Jun 20237:00 amRNSNotification of Major Holdings
16th Jun 20237:00 amRNSScrip Dividend Reference Price
7th Jun 20233:53 pmRNSDirector’s Shareholding
5th Jun 20233:39 pmRNSFinal Dividend Timetable
5th Jun 20237:00 amRNSDirector’s/PCA Shareholdings
1st Jun 20237:00 amRNSGrant of LTIP Award
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
31st May 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
26th May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSChange of Adviser
11th May 20237:00 amRNSDirectors' Disclosure
11th Apr 20237:00 amRNSDirector's/PCAs' Shareholding
5th Apr 20237:00 amRNSGrant of LTIP Award and Director Dealing
5th Apr 20237:00 amRNSDirector/PCA Shareholdings
4th Apr 20237:00 amRNSDirectorate Change
4th Apr 20237:00 amRNSQuarterly Syndicate Mid Point Forecasts
10th Jan 20237:00 amRNS2023 Helios Retained Capacity Update
29th Dec 20223:38 pmRNSAcquisitions of LLVs, Issue of Equity and TVR
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 202212:06 pmRNSHolding(s) in Company
19th Dec 20229:07 amRNSGrant of LTIP Awards and Directors' Dealings
14th Dec 202212:47 pmRNSHolding(s) in Company
13th Dec 202211:29 amRNSResult of GM, TVR and Directors' Participation
12th Dec 20227:00 amRNSResult of Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.